Vascular Solutions, Inc.  

(Public, NASDAQ:VASC)   Watch this stock  
Find more results for VASC
May 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 19.26 - 35.94
Open     -
Vol / Avg. 0.00/126,363.00
Mkt cap 571.27M
P/E 48.14
Div/yield     -
EPS 0.69
Shares 17.26M
Beta -0.01
Inst. own 70%
Jul 20, 2015
Q2 2015 Vascular Solutions Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 13, 2015
Vascular Solutions Inc at Bank of America Merrill Lynch Health Care Conference
Apr 21, 2015
Q1 2015 Vascular Solutions Inc Earnings Call
Apr 21, 2015
Q1 2015 Vascular Solutions Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 6.38% 10.10%
Operating margin 9.89% 15.80%
EBITD margin - 19.69%
Return on average assets 6.85% 10.81%
Return on average equity 7.76% 12.15%
Employees 485 -
CDP Score - -


6464 Sycamore Ct N
MAPLE GROVE, MN 55369-6032
United States - Map
+1-763-6564300 (Phone)
+1-877-6564251 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Vascular Solutions, Inc. (Vascular) is a medical device company focused on providing clinically advanced solutions to interventional cardiologists and interventional radiologists. Vascular offers product and service in three categories: catheter products, hemostat products and vein products and services. Catheter products consists of catheters used in minimally invasive medical procedures for the diagnosis or treatment of vascular conditions and also including products used in connection with gaining percutaneous access to the vasculature to perform minimally invasive procedures. Hemostat (blood clotting) products consist of the D-Stat Dry hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding, and the D-Stat Flowable. Vein products consists of the Vari-Lase endovenous laser, a laser console and procedure kit used for the treatment of varicose veins.

Officers and directors

John L. Erb Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Howard C. Root Chief Executive Officer and Director
Age: 54
Bio & Compensation  - Reuters
James Hennen Chief Financial Officer, Senior Vice President - Finance, Corporate Secretary
Age: 42
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William Rutstein Senior Vice President - International Sales
Age: 62
Bio & Compensation  - Reuters
Chad J. Kugler Senior Vice President - Research and Development
Age: 43
Bio & Compensation  - Reuters
Charmaine Sutton Senior Vice President - Operations
Age: 55
Bio & Compensation  - Reuters
Susan Christian Vice President - Sales Operations
Age: 45
Bio & Compensation  - Reuters
Carrie Powers Vice President - Marketing
Age: 40
Bio & Compensation  - Reuters
Phillip E. Nalbone Vice President - Corporate Development
Age: 52
Bio & Compensation  - Reuters
Brett Demchuk Vice President - Product Quality
Age: 49
Bio & Compensation  - Reuters